Literature DB >> 9003749

Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent?

R O Darouiche1, G C Landon, J M Patti, L L Nguyen, R C Fernau, D McDevitt, C Greene, T Foster, M Klima.   

Abstract

Bacterial colonisation of prosthetic material can lead to clinical infection or implant failure, or both, often requiring removal of the device. Adherence of Staphylococcus aureus to bioprosthetic materials is mediated by adhesins belonging to the MSCRAMM (microbial surface components recognising adhesive matrix molecules) family of microbial cell surface proteins. The objective of this study was to compare the virulence of a mutant strain of S. aureus Newman that possesses all three fibrinogen-, fibronectin- and collagen-binding MSCRAMMs (MSCRAMM-positive strain) with that of a mutant strain that lacks all three types of MSCRAMMs (MSCRAMM-negative strain) in a rabbit model of orthopaedic device-related infection. After a hole was drilled into the knee joint of each animal, a group of 10 rabbits was inoculated with the MSCRAMM-positive strain and another group of 10 rabbits received the MSCRAMM-negative strain. A stainless steel screw was then placed into the drilled hole. Two weeks later, the rabbits were killed and serum samples, bone tissue and implants were harvested for bacteriological and histopathological evaluation. No significant difference in infection rates was demonstrated between the two groups. The ability to delineate the role of S. aureus surface adhesins in causing orthopaedic device-related infection could be model-dependent.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9003749     DOI: 10.1099/00222615-46-1-75

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  9 in total

1.  The use of bone cement for the localized, controlled release of the antibiotics vancomycin, linezolid, or fusidic acid: effect of additives on drug release rates and mechanical strength.

Authors:  John Jackson; Fay Leung; Clive Duncan; Clement Mugabe; Helen Burt
Journal:  Drug Deliv Transl Res       Date:  2011-04       Impact factor: 4.617

2.  Truncation of fibronectin-binding proteins in Staphylococcus aureus strain Newman leads to deficient adherence and host cell invasion due to loss of the cell wall anchor function.

Authors:  Matthias Grundmeier; Muzaffar Hussain; Petra Becker; Christine Heilmann; Georg Peters; Bhanu Sinha
Journal:  Infect Immun       Date:  2004-12       Impact factor: 3.441

Review 3.  Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management.

Authors:  Steven Y C Tong; Joshua S Davis; Emily Eichenberger; Thomas L Holland; Vance G Fowler
Journal:  Clin Microbiol Rev       Date:  2015-07       Impact factor: 26.132

Review 4.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

5.  New perspectives of infections in cardiovascular disease.

Authors:  Ignatius W Fong
Journal:  Curr Cardiol Rev       Date:  2009-05

Review 6.  A systematic review of animal models for Staphylococcus aureus osteomyelitis.

Authors:  W Reizner; J G Hunter; N T O'Malley; R D Southgate; E M Schwarz; S L Kates
Journal:  Eur Cell Mater       Date:  2014-03-25       Impact factor: 3.942

7.  Increased virulence of a fibronectin-binding protein mutant of Staphylococcus aureus in a rat model of pneumonia.

Authors:  Mary C McElroy; David J Cain; Christine Tyrrell; Timothy J Foster; Christopher Haslett
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

Review 8.  Innovations in osteomyelitis research: A review of animal models.

Authors:  Kylie M Roux; Leah H Cobb; Marc A Seitz; Lauren B Priddy
Journal:  Animal Model Exp Med       Date:  2021-01-13

9.  Characterization of Phenolic Acid Antimicrobial and Antioxidant Structure-Property Relationships.

Authors:  Jingyi Liu; Changling Du; Henry T Beaman; Mary Beth B Monroe
Journal:  Pharmaceutics       Date:  2020-05-02       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.